Related Experiment Video

Updated: May 13, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Promising new molecular targeted therapies in head and neck cancer

Kelly Dorsey1, Mark Agulnik

  • 1Robert H. Lurie Comprehensive Cancer Center and Division of Hematology/Oncology, Northwestern University, 676 N. St. Clair, Suite 850, Chicago, IL 60611, USA.

Drugs
|February 27, 2013
PubMed

Insights

Advances in targeted therapies offer new hope for head and neck squamous cell carcinoma (HNSCC) treatment. Research explores novel agents like EGFR and VEGFR inhibitors to improve outcomes and reduce toxicity in HNSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Squamous cell carcinoma of the head and neck (SCCHN) treatment faces challenges with poor survival and high toxicity despite multimodality therapies.
  • Human papillomavirus (HPV) status is recognized for its prognostic value in SCCHN.
  • Biologically targeted therapies offer potential for improved selectivity and reduced toxicity in SCCHN treatment.

Purpose of the Study:

  • To review the current landscape of targeted agents in SCCHN treatment.
  • To highlight emerging therapies and ongoing clinical trials for SCCHN.

Main Methods:

  • Review of approved and investigational targeted agents for SCCHN.
  • Identification of targeted pathways including EGFR, VEGFR, PI3K/AKT/mTOR, MET, and IGF-1R.
  • Summary of ongoing clinical trials evaluating these agents and combinations.

Main Results:

  • Targeted agents include EGFR monoclonal antibodies and tyrosine kinase inhibitors.
  • VEGFR inhibitors are also under investigation for SCCHN.
  • Inhibitors of PI3K/AKT/mTOR, MET, and IGF-1R pathways represent further therapeutic avenues.

Conclusions:

  • Targeted therapies, including EGFR and VEGFR inhibitors, represent significant developments in SCCHN understanding and treatment.
  • Ongoing clinical trials are crucial for evaluating the efficacy and safety of these novel agents and their combinations in SCCHN.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...